001     136699
005     20240321220123.0
024 7 _ |a 10.1007/s12311-012-0378-2
|2 doi
024 7 _ |a pmid:22528963
|2 pmid
024 7 _ |a 1473-4222
|2 ISSN
024 7 _ |a 1473-4230
|2 ISSN
037 _ _ |a DZNE-2020-03021
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Synofzik, Matthis
|0 P:(DE-2719)2811275
|b 0
|e First author
245 _ _ |a Characterizing POLG ataxia: clinics, electrophysiology and imaging.
260 _ _ |a London
|c 2012
|b Dunitz
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2012-04-12
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2012-12-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1590591701_12712
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Mutations in the mitochondrial DNA polymerase gamma (POLG) cause a highly pleomorphic disease spectrum, and reports about their frequencies in ataxia populations yield equivocal results. This leads to uncertainties about the role of POLG genetics in the workup of patients with unexplained ataxia. A comprehensive characterization of POLG-associated ataxia (POLG-A) will help guide genetic diagnostics and advance our understanding of the disease processes underlying POLG-A. Thirteen patients with POLG-A were assessed by standardized clinical investigation, nerve conduction studies, motor-evoked potentials, magnetic resonance imaging (MRI) and transcranial sonography (TCS). The findings were compared with 13 matched patients with Friedreich's ataxia (FA). In addition to the well-known POLG-associated features of chronic external ophthalmoplegia (100 %), areflexia to the lower extremity (100 %), impaired vibration sense (100 %), bilateral ptosis (69 %) and epilepsy (38 %), also hyperkinetic movement disorders were frequent in POLG-A patients, including chorea (31 %), dystonia (31 %) and myoclonus (23 %). Similar to FA, polyneuropathy was of sensory axonal type (100 %). In contrast to FA, none of the POLG-A patients showed impaired central motor conduction. TCS demonstrated less enlargement of the fourth ventricle and more diffuse cerebellar hyperechogenicity in POLG-A. Corresponding to TCS, MRI revealed no or only mild cerebellar atrophy in most POLG-A patients (85 %). POLG ataxia presents with the clinical characteristics of both afferent and cerebellar ataxia. Cerebellar alterations diffusely involve various parts of the cerebellum, yet cerebellar atrophy is generally mild. POLG-A presents with a high load of distinct non-ataxia features, namely, sensory neuropathy, external ophthalmoplegia, ptosis, epilepsy and/or hyperkinetic movement disorders. Involvement of the corticospinal tract, however, is rare.
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 0
542 _ _ |i 2012-04-12
|2 Crossref
|u http://www.springer.com/tdm
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a DNA Polymerase gamma
|0 EC 2.7.7.7
|2 NLM Chemicals
650 _ 7 |a DNA-Directed DNA Polymerase
|0 EC 2.7.7.7
|2 NLM Chemicals
650 _ 7 |a POLG protein, human
|0 EC 2.7.7.7
|2 NLM Chemicals
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Brain: pathology
|2 MeSH
650 _ 2 |a DNA Polymerase gamma
|2 MeSH
650 _ 2 |a DNA-Directed DNA Polymerase: genetics
|2 MeSH
650 _ 2 |a DNA-Directed DNA Polymerase: metabolism
|2 MeSH
650 _ 2 |a Electromagnetic Phenomena
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Friedreich Ataxia: genetics
|2 MeSH
650 _ 2 |a Friedreich Ataxia: pathology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging: methods
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Mutation: genetics
|2 MeSH
650 _ 2 |a Young Adult
|2 MeSH
700 1 _ |a Srulijes, Karin
|0 P:(DE-2719)9000298
|b 1
700 1 _ |a Godau, Jana
|0 P:(DE-2719)9000100
|b 2
700 1 _ |a Berg, Daniela
|0 P:(DE-2719)2000059
|b 3
700 1 _ |a Schöls, Ludger
|0 P:(DE-2719)2810795
|b 4
|e Last author
773 1 8 |a 10.1007/s12311-012-0378-2
|b : Springer Science and Business Media LLC, 2012-04-12
|n 4
|p 1002-1011
|3 journal-article
|2 Crossref
|t The Cerebellum
|v 11
|y 2012
|x 1473-4222
773 _ _ |a 10.1007/s12311-012-0378-2
|g Vol. 11, no. 4, p. 1002 - 1011
|0 PERI:(DE-600)2071266-2
|n 4
|q 11:4<1002 - 1011
|p 1002-1011
|t The Cerebellum
|v 11
|y 2012
|x 1473-4222
909 C O |p VDB
|o oai:pub.dzne.de:136699
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2811275
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9000298
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9000100
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2000059
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2810795
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|2 G:(DE-HGF)POF3-300
|v Population Studies and Genetics
|x 0
914 1 _ |y 2012
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CEREBELLUM : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-2719)5000005
|k AG Schöls 1
|l Clinical Neurogenetics
|x 0
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser 1
|l Parkinson Genetics
|x 1
920 1 _ |0 I:(DE-2719)5000055
|k AG Berg
|l Parkinson's Disease Genetics AG Berg
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000005
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)5000055
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.1016/S1474-4422(07)70054-6
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S1474-4422(07)70054-6
999 C 5 |a 10.1186/1750-1172-1-47
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/1750-1172-1-47
999 C 5 |a 10.1002/mds.23286
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.23286
999 C 5 |a 10.1086/444548
|9 -- missing cx lookup --
|2 Crossref
|o 10.1086/444548
999 C 5 |a 10.1016/j.jns.2007.01.005
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.jns.2007.01.005
999 C 5 |a 10.1007/s00415-008-0772-3
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00415-008-0772-3
999 C 5 |y 2007
|2 Crossref
|o K Craig 2007
999 C 5 |a 10.1093/brain/awl097
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/awl097
999 C 5 |a 10.1093/brain/awl088
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/awl088
999 C 5 |2 Crossref
|o
999 C 5 |a 10.1002/humu.20824
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/humu.20824
999 C 5 |a 10.1136/jmg.2009.067686
|9 -- missing cx lookup --
|2 Crossref
|o 10.1136/jmg.2009.067686
999 C 5 |a 10.1212/01.wnl.0000219042.60538.92
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/01.wnl.0000219042.60538.92
999 C 5 |a 10.1093/brain/104.3.589
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/104.3.589
999 C 5 |a 10.1212/01.wnl.0000325057.33666.72
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/01.wnl.0000325057.33666.72
999 C 5 |a 10.1212/WNL.0b013e31822e7ca0
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/WNL.0b013e31822e7ca0
999 C 5 |a 10.1159/000327751
|9 -- missing cx lookup --
|2 Crossref
|o 10.1159/000327751
999 C 5 |a 10.1016/S1474-4422(08)70239-4
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S1474-4422(08)70239-4
999 C 5 |a 10.1093/brain/awq067
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/awq067
999 C 5 |a 10.1002/ana.410420615
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/ana.410420615
999 C 5 |a 10.2307/2529310
|9 -- missing cx lookup --
|2 Crossref
|o 10.2307/2529310
999 C 5 |a 10.1212/WNL.0b013e3181b78488
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/WNL.0b013e3181b78488
999 C 5 |a 10.1002/mds.23307
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.23307
999 C 5 |a 10.1002/mds.23960
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.23960
999 C 5 |a 10.1212/01.WNL.0000156516.77696.5A
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/01.WNL.0000156516.77696.5A
999 C 5 |a 10.1016/0022-510X(82)90095-8
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/0022-510X(82)90095-8
999 C 5 |a 10.1007/s00702-010-0504-6
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00702-010-0504-6


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21